Real-time enrollment status for this heart failure with preserved ejection fraction (hfpef) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:21 AM UTC
| NCT Number | NCT06560762 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Preserved Ejection Fraction (HFpEF) |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Secretome Therapeutics |
| Last Updated on CT.gov | April 6, 2025 (Apr 6, 2025) |
As of August 28, 2026: Clinical trial NCT06560762 is currently recruiting participants. This phase1 study for heart failure with preserved ejection fraction (hfpef) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Secretome Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06560762 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06560762 was last updated Apr 6, 2025 (April 6, 2025). HelloStudys verifies this status automatically.